Status unknownNCT05075148KOA-RIUpdated Oct 12, 2021

Aneurysmal Bone Cyst Imaging After Interventional Radiology Treatment

An observational study in Bone Cysts, sponsored by University Hospital, Montpellier. Status unknown at 1 site in France. Open to participants aged 0 Years and older. Per ClinicalTrials.gov, last updated 2021-10-12.

Sponsored by University Hospital, Montpellier · Observational

The sponsor has not verified this record recently (last verified Jul 2021), so the status shown — last known as Enrolling by invitation — may be out of date.

Study type: Observational
Model: Case-only
Time perspective: Retrospective
Enrollment: 20
Ages: 0 Years and older
Sex: All

Study summary

This study aims to describe the clinical outcomeand the radiological appearance of aneurysmal bone cyst treated by means of interventional radiology procedures (percutaneous sclerosis and endovascular embolization)

Conditions studied

Bone Cysts

Browse trials for

Bone Cysts 18

Keywords

Radiology, Interventional
Epidemiology
Vascualr embolisation
Percutaneous alcoholization
Aneurysmal bone cyst

In context

Bone Cysts

18 studies on the registry are indexed under Bone Cysts; 5 are open to participants now.

Browse Bone Cysts studies →

Lead sponsor

University Hospital, Montpellier is the lead sponsor of 1,261 studies on the registry; 224 are open to participants now.

Browse University Hospital, Montpellier studies →

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 0 Years and older
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Non-probability sample

Study population

Aneurysmal bone cyst

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Male of female
Aging from 0 to 30 years
With typical aneurysmal bone cyst at initial imaging
At least one interventional radiology procedure performed

Exclusion criteria

Exclusion criteria:

No initial surgery
Patient refuses to participate

Study design

Observational model: Case-only
Time perspective: Retrospective
Enrollment: 20 participants (estimated)
Patient registry: No

Groups and cohorts

Aneurysmal bone cyst
Patient aging from 0 to 30 years with diagnosis of aneurysmal bone cyst treated by percutaneous alcolisation or endovascular embolization.
Other: radiology

Interventions

Otherradiology
Interventional radiology for aneurysmal bone cyst ( percutaneous alcoholization, vascualr embolisation)

What researchers measure

Primary outcomes

Difference of size lesion after treatement
Percentage of peripheral reossification after treatment : * 0%: no reossification * \< 25%: low reossification * Between 25% -50%: Partial reossification * Between 50-75%: significant reossification * \> 75%: very significant reossification * 100%: complete reossifcation
Time frame: day 1

Secondary outcomes

Number of pain
Pain measured with Pain scale ( 0 = no pain , 10 = maximum pain)
Time frame: day 1
number of deficience
Number of patients needs second treatment 3- Fracture ? (yes or no)
Time frame: day 1
number of complication
Fracture ? (yes or no)
Time frame: day 1

Study locations

1 site

Uhmontpellier
Montpellier, 34295, France

References and documents

Individual participant data

Plan to share: Undecided — NC

No publications or documents are linked to this record.

Timeline

Tracking since Sep 25, 2026

ElapsedEstimatedEstimated, not yet reached

Started Jan 2021 (actual). Primary completion is estimated for Dec 2021, 11 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered: Jul 5, 2021
First posted: Oct 12, 2021
StartActual: Jan 1, 2021
Primary completionEst.: Dec 1, 2021
CompletionEst.: Mar 30, 2022
Last update: Oct 12, 2021

What these dates mean

Start.: When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.: When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.: When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.: Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.

No changes since tracking began. The registry record was last updated on Oct 12, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT05075148
Lead sponsor: University Hospital, Montpellier
Responsible party: Sponsor
First posted: Oct 12, 2021
Start date: Jan 1, 2021
Primary completion: Dec 1, 2021 (estimated)
Completion: Mar 30, 2022 (estimated)
Last update: Oct 12, 2021

Study contacts

Catherine CYTEVAL, MD.PhD

study director · University Hospital, Montpellier

Oversight

Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Bone Cysts →

Other studies from this sponsor

University Hospital, Montpellier →

Start the discussion